20
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Corticosterone primes the neuroinflammatory response to Gulf War Illness‐relevant organophosphates independently of acetylcholinesterase inhibition

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Gulf War Illness ( GWI) is a chronic multi‐symptom disorder affecting veterans of the 1991 Gulf War. Among the symptoms of GWI are those associated with sickness behavior, observations suggestive of underlying neuroinflammation. We have shown that exposure of mice to the stress hormone, corticosterone ( CORT), and to diisopropyl fluorophosphate ( DFP), as a nerve agent mimic, results in marked neuroinflammation, findings consistent with a stress/neuroimmune basis of GWI. Here, we examined the contribution of irreversible and reversible acetylcholinesterase ( AChE) inhibitors to neuroinflammation in our mouse model of GWI. Male C57 BL/6J mice received 4 days of CORT (400 mg/L) in the drinking water followed by a single dose of chlorpyrifos oxon ( CPO; 8 mg/kg, i.p.), DFP (4 mg/kg, i.p.), pyridostigmine bromide (PB; 3 mg/kg, i.p.), or physostigmine ( PHY; 0.5 mg/kg, i.p.). CPO and DFP alone caused cortical and hippocampal neuroinflammation assessed by qPCR of tumor necrosis factor‐alpha, IL‐6, C–C chemokine ligand 2, IL‐1β, leukemia inhibitory factor and oncostatin M; CORT pretreatment markedly augmented these effects. Additionally, CORT exposure prior to DFP or CPO enhanced activation of the neuroinflammation signal transducer, signal transducer and activator of transcription 3 (STAT3). In contrast, PHY or PB alone or with CORT pretreatment did not produce neuroinflammation or STAT3 activation. While all of the CNS‐acting AChE inhibitors ( DFP, CPO, and PHY) decreased brain AChE activity, CORT pretreatment abrogated these effects for the irreversible inhibitors. Taken together, these findings suggest that irreversible AChE inhibitor‐induced neuroinflammation and particularly its exacerbation by CORT, result from non‐cholinergic effects of these compounds, pointing potentially to organophosphorylation of other neuroimmune targets.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: not found

          Cytokine-induced sickness behaviour: mechanisms and implications.

          Sickness behaviour represents the expression of the adaptive reorganization of the priorities of the host during an infectious episode. This process is triggered by pro-inflammatory cytokines produced by peripheral phagocytic cells in contact with invading micro-organisms. The peripheral immune message is relayed to the brain via a fast neural pathway and a slower humoral pathway, resulting in the expression of pro-inflammatory cytokines in macrophage-like cells and microglia in the brain. The cellular and molecular components of this previously unsuspected system are being progressively identified. These advances are opening new avenues for understanding brain disorders, including depression.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            How corticosteroids control inflammation: Quintiles Prize Lecture 2005.

            Corticosteroids are the most effective anti-inflammatory therapy for many chronic inflammatory diseases, such as asthma but are relatively ineffective in other diseases such as chronic obstructive pulmonary disease (COPD). Chronic inflammation is characterised by the increased expression of multiple inflammatory genes that are regulated by proinflammatory transcription factors, such as nuclear factor-kappaB and activator protein-1, that bind to and activate coactivator molecules, which then acetylate core histones to switch on gene transcription. Corticosteroids suppress the multiple inflammatory genes that are activated in chronic inflammatory diseases, such as asthma, mainly by reversing histone acetylation of activated inflammatory genes through binding of liganded glucocorticoid receptors (GR) to coactivators and recruitment of histone deacetylase-2 (HDAC2) to the activated transcription complex. At higher concentrations of corticosteroids GR homodimers also interact with DNA recognition sites to active transcription of anti-inflammatory genes and to inhibit transcription of several genes linked to corticosteroid side effects. In patients with COPD and severe asthma and in asthmatic patients who smoke HDAC2 is markedly reduced in activity and expression as a result of oxidative/nitrative stress so that inflammation becomes resistant to the anti-inflammatory actions of corticosteroids. Theophylline, by activating HDAC, may reverse this corticosteroid resistance. This research may lead to the development of novel anti-inflammatory approaches to manage severe inflammatory diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The cholinergic anti-inflammatory pathway.

              The regulation of the innate immune response is critical for controlling inflammation and for the prevention and treatment of diseases. We recently demonstrated that the efferent vagus nerve inhibits pro-inflammatory cytokine release and protects against systemic inflammation, and termed this vagal function "the cholinergic anti-inflammatory pathway." The discovery that the innate immune response is regulated partially through this neural pathway provides a new understanding of the mechanisms that control inflammation. In this review, we outline the cholinergic anti-inflammatory pathway and summarize the current insights into the mechanisms of cholinergic modulation of inflammation. We also discuss possible clinical implications of vagus nerve stimulation and cholinergic modalities in the treatment of inflammatory diseases.
                Bookmark

                Author and article information

                Contributors
                jdo5@cdc.gov
                Journal
                J Neurochem
                J. Neurochem
                10.1111/(ISSN)1471-4159
                JNC
                Journal of Neurochemistry
                John Wiley and Sons Inc. (Hoboken )
                0022-3042
                1471-4159
                14 June 2017
                August 2017
                : 142
                : 3 ( doiID: 10.1111/jnc.2017.142.issue-3 )
                : 444-455
                Affiliations
                [ 1 ] Health Effects Laboratory Division Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Morgantown West Virginia USA
                Author notes
                [*] [* ]Address correspondence and reprint requests to James P. O'Callaghan, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Mailstop L‐3014, Morgantown, WV 26505, USA. E‐mail: jdo5@ 123456cdc.gov
                Author information
                http://orcid.org/0000-0001-8497-4598
                Article
                JNC14071
                10.1111/jnc.14071
                5575502
                28500787
                af96e2ad-a165-4108-a069-85ff43c17aee
                Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 11 April 2017
                : 29 April 2017
                : 08 May 2017
                Page count
                Figures: 6, Tables: 0, Pages: 12, Words: 8255
                Funding
                Funded by: Centers for Disease Control and Prevention
                Funded by: National Institute for Occupational Safety and Health
                Funded by: Congressionally Directed Medical Research Programs
                Funded by: Gulf War Illness Research Program Grants
                Award ID: GW080150
                Award ID: GW120037
                Award ID: GW120045
                Categories
                Original Article
                ORIGINAL ARTICLES
                Neuroinflammation & Neuroimmunology
                Custom metadata
                2.0
                jnc14071
                August 2017
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.8 mode:remove_FC converted:30.08.2017

                Neurosciences
                chlorpyrifos,diisopropyl fluorophosphate,neuroinflammation,physostigmine,pyridostigmine bromide,stat3

                Comments

                Comment on this article